Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Acute AB
AB
Active
Org 5593715930
Väpnargatan 25
Beauty care and other beauty treatment activities · NACE 9622
Est. 2022
1-4 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 177K
+35% vs 2023
EBITDA margin
-19.1%
-36% vs 2023
Equity ratio
34.6%
Financial strength
Net profit 2024
SEK -34K
-35% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 177K
+35%
EBITDA
SEK -34K
-36%
Net profit
SEK -34K
-35%
Total assets
SEK 73K
+39%
Equity
SEK 25K
+100%
Employees
—
—
Company information
Legal name
Acute AB
Org number
5593715930
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
22 mars 2022
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Legitimerad sjuksköterska som utför estetiska injektioner med fillers, botulium toxin och därmed förenlig verksamhet.
Contact
Address
Väpnargatan 25
Email
varviksalongen@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Beauty care and other beauty treatment activities
Companies in Gävle
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2022
2022
2023
2024
Revenue
73
73
131
177
Staff expenses
—
−0
−0
—
EBITDA
−37
−37
−25
−34
Depreciation & amort.
−0
−0
—
—
EBIT
−37
−37
−25
−34
Net financials
—
0
−0
−0
Profit before tax
−37
−37
−25
−34
Tax
−0
−0
—
—
Net profit
−37
−37
−25
−34
Balance sheet
SEK thousands
Item
2022
2022
2023
2024
Total assets
80
80
53
73
Equity
38
38
13
25
Long-term debt
0
0
—
—
Short-term debt
43
43
40
48
Total debt
43
43
40
48
Financial ratios
5-year trend
EBITDA margin
-19.1%
This company
15.8%
Market median
-221% vs market
2022
2024
Equity ratio
34.6%
This company
38.2%
Market median
+9% vs market
2022
2024
Return on equity
-133.9%
This company
18.4%
Market median
-828% vs market
2022
2024
Net profit margin
-19.2%
This company
8.1%
Market median
-337% vs market
2022
2024
Asset turnover
2.42×
This company
1.12×
Market median
+116% vs market
2022
2024
Debt / equity
1.89×
This company
0.62×
Market median
-205% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-03-22 – 2022-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-03-01 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
LL
Lisa Lo Norling
Board of Directors
2022
JS
Joel Svensson
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Acute AB also hold positions in
0
other companies.
Person
Role here
Other companies
Lisa Lo Norling
Board of Directors
0 companies
Joel Svensson
Deputy Board Member
0 companies